76. The representative of Chile said that the three main requirements for patentability established under Article 27.1 of the TRIPS Agreement, i.e. novelty, inventive step and industrial applicability should be fully implemented by IP offices and, were that to happen, there should be no contradiction or conflict with the appropriation of naturally occurring life forms. It was vital for national and regional patent offices to have access to all the information available so as to avoid granting erroneous patents. Databases could be of great use in that regard. As Chile had endemic unique genetic resources, it was looking into the development of a system that would regulate those resources in compliance with its international commitments. In that context, Chile was analyzing the benefits of the disclosure requirement. He welcomed the work being carried out on that issue in other forums, in particular the IGC, and hoped an increase in the number of the meetings of the IGC in 2012 would allow for major progress in that regard.
